SBK-012
N/A
Report date: 2023/03/27 14:10:22
Base Information
Drug NameSBK-012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A